Avadel Pharmaceuticals Plc (AVDL)

21.38 -0.04 (-0.19%) USD  |  NASDAQ  |  Dec 16, 12:25
More

Avadel Pharmaceuticals Research and Development Expense (Annual): 15.20M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AVDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Alkermes Plc 239.63M
Jazz Pharmaceuticals Plc 884.00M
Amarin Corp. Plc 17.86M
Perrigo Co. Plc 112.20M
Arcturus Therapeutics Holdings, Inc. 124.69M